Boston Epigenetics Society (BES) Meeting Feb 2024- Samir Ounzain, HAYA Therapeutics
ฝัง
- เผยแพร่เมื่อ 28 ก.ย. 2024
- Recording of the Boston Epigenetics Society (BES) online meeting February 29, 2024 with Samir Ounzain, Ph.D., CEO and Co-Founder of HAYA Therapeutics.
"Unlocking the Regulatory Genome: Pioneering RNA-Guided Therapeutics for Cell-State Modulation in Disease Pathogenesis"
Very inspirational talk!
Thank you!